A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

Name: A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa
Published: 2025
License: Public Domain

Beacon Therapeutics · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

adeno associatedvirus genetherapy

x-linked retinitis pigmentosa (xlrp), xlrp, retinal degeneration, rpgr, adeno-associated virus, aav, gene therapy, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

Related documents